P. Paterlini-Bréchot
Oncology · 2001–2008
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 26 citations into it; #754 of 1,698 by trust here, #923 by citations
- Cancer Research — 16 citations into it; #812 of 1,780 by trust here, #1,666 by citations
- Biotechnology — 8 citations into it
Whom P. Paterlini-Bréchot trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts P. Paterlini-Bréchot overall
Papers from P. Paterlini-Bréchot's perspective
Ordered by how strongly the researchers P. Paterlini-Bréchot trusts endorse each paper. Same corpus, a different order for every researcher.
- Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases (Clinical Cancer Research)
- Tumour-cell invasion and migration: diversity and escape mechanisms (Nature Reviews. Cancer)
- Complex networks orchestrate epithelial–mesenchymal transitions (Nature reviews. Molecular cell biology)
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited (Nature Reviews. Cancer)
- Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. (Cell)
- A molecular signature of metastasis in primary solid tumors (Nature Genetics)
- The Hallmarks of Cancer Review
- Hypoxia signalling in cancer and approaches to enforce tumour regression (Nature)
- Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis (Nature Medicine)
- Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. (Cancer Research)
Their papers
- Regulation of autophagy by cytoplasmic p53 (2008) — 1,171 citations
- Circulating tumor cells (CTC) detection: clinical impact and future directions. (2007) — 967 citations
- Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”? (2001) — 607 citations